Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented the data at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD).
Qu.E.S.T. Investigator David Goodman, M.D., director of the Adult Attention Deficit Disorder Center of Maryland, Lutherville, Maryland says, "Qu.E.S.T. is the largest study of its kind to date to document improvements in symptoms of adult ADHD. The good news for adults with ADHD is that Adderall XR was shown to improve ADHD symptoms and was also generally well tolerated."
Qu.E.S.T. is a 30-week, open-label, multicenter investigation of adults, aged 18 and older, diagnosed with ADHD who receive treatment with once-daily Adderall XR.
